Cargando…
Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance
Cardiovascular disease is an emerging medical issue in patients with hemophilia (PWH) and its prevalence is increasing up to 15% in PWH in the United States. Atrial fibrillation, acute and chronic coronary syndromes, venous thromboembolism, and cerebral thrombosis are frequent thrombotic or prothrom...
Autores principales: | Schutgens, Roger E.G., Jimenez-Yuste, Victor, Escobar, Miguel, Falanga, Anna, Gigante, Bruna, Klamroth, Robert, Lassila, Riitta, Leebeek, Frank W.G., Makris, Michael, Owaidah, Tarek, Sholzberg, Michelle, Tiede, Andreas, Werring, David J., van der Worp, H. Bart, Windyga, Jerzy, Castaman, Giancarlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256340/ https://www.ncbi.nlm.nih.gov/pubmed/37304933 http://dx.doi.org/10.1097/HS9.0000000000000900 |
Ejemplares similares
-
“ISTH guidelines for antithrombotic treatment in COVID‐19”: Reply
por: Schulman, Sam, et al.
Publicado: (2022) -
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer
por: Falanga, Anna, et al.
Publicado: (2022) -
Reliability and Feasibility of the Self-Administered ISTH-Bleeding Assessment Tool
por: Punt, Marieke C., et al.
Publicado: (2019) -
Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report
por: Rodeghiero, Francesco, et al.
Publicado: (2019) -
ISTH Abstract
Publicado: (2022)